𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Further evidence of the benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection

✍ Scribed by Sperl, Jan; Frankova, Sona; Spicak, Julius; Viklicky, Ondrej

Book ID
122200037
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
326 KB
Volume
58
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Antiviral treatment of chronic hepatitis
Antiviral treatment of chronic hepatitis B virus infection: Improvement in liver disease with interferon and adenine arabinoside
✍ George H. Scullard; Ljudevit L. Andres; Harry B. Greenberg; Joseph L. Smith; Vin πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 398 KB πŸ‘ 1 views

Twelve of 32 patients lost HBeAg and DNA polymerase from their serum after completing antiviral therapy with interferon and/or adenine arabinoside. Three lost serum HBsAg as well. Loss of corresponding viral markers from hepatic tissue was also seen. There was improvement in symptoms, hepatic tests,

Interferon antibodies may negate the ant
Interferon antibodies may negate the antiviral effects of recombinant Ξ±-interferon treatment in patients with chronic hepatitis B virus infection
✍ Dr. Anna Suk-Fong Lok; Ching-Lung Lai; Elsie Kit-Yee Leung πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 508 KB

In a randomized controlled trial of recombinant a-2a interferon for chronic hepatitis B, interferon antibodies developed in 21 (39%) of 54 Chinese adults who received IFN. No correlation was observed between sex, age, pretreatment serum ALT level or liver histological findings and the development of